Evidence map›Paper›PMID 9707629›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve.

C Matute

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 124 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Myelin sheath structure and regeneration in peripheral nerve injury repair.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.International journal of molecular sciences · 2017
    Review
  8. Article
  9. Review
  10. Review
  11. Demyelination in multiple sclerosis.Handbook of clinical neurology · 2014
    Review
  12. Optic neuritis in neuromyelitis optica.Progress in retinal and eye research · 2013
    Article
  13. Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  14. Article
  15. Therapeutic potential of kainate receptors.CNS neuroscience & therapeutics · 2011
    Review
  16. Review
  17. Article
  18. Article
  19. Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

C MatuteDepartamento de Neurociencias, Universidad del País Vasco, 48940-Leioa, Vizcaya, Spain.
University of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroglial cells express ionotropic glutamate receptors. In the adult optic nerve, reverse transcription-PCR showed that the native receptors are formed by subunits belonging to the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate classes. Because activation of AMPA and kainate receptors can be toxic to oligodendrocytes in vitro, I examined the nature of the damage caused by kainate, an agonist of both receptor classes, applied directly onto the optic nerve. Acute infusion or chronic slow delivery of the agonist caused massive nerve damage that was more extensive in the latter. Interestingly, chronic delivery also produced inflammation and demyelination in well circumscribed areas of the nerve, together with other pathological features that closely resemble those observed in multiple sclerosis patients. Acute and chronic kainate lesions were both prevented by the non-N-methyl-D-aspartate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione. However, GYKI53655, a specific AMPA receptor antagonist, did not significantly reduce the size of the lesion, suggesting that the kainate toxicity was mainly mediated through activation of kainate-preferring glutamate receptors. These observations suggest that alterations in glutamate signaling may be detrimental to oligodendrocytes and may be involved in the pathogenesis of multiple sclerosis and other demyelinating diseases.

Indexed as

Optic Nerve Injuries6-Cyano-7-nitroquinoxaline-2,3-dioneAnimalsCell DeathDemyelinating DiseasesDisease Models, AnimalExcitatory Amino Acid AgonistsHumansKainic AcidKainic Acid ReceptorsMultiple SclerosisMyelin SheathOligodendrogliaOptic NervePolymerase Chain ReactionRats6-Cyano-7-nitroquinoxaline-2,3-dioneExcitatory Amino Acid AgonistsKainic AcidKainic Acid ReceptorsReceptors, AMPA

Identifiers

PMID9707629
PMCPMC21490
OpenAlexW2095402874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.